Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study
Condition: Prostate Carcinoma Interventions: Drug: Darolutamide; Drug: Goserelin Acetate; Drug: Leuprolide Acetate; Drug: Placebo Administration; Other: Quality-of-Life Assessment; Drug: Triptorelin Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Hormonal Therapy | Hormones | Prostate Cancer | Research | Study